Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

6000 ND:YAG LASER FOR BENIGN/MALIGNANT OBSTRUCTION

K-Number: K862698 · 1986-08-05

ApplicantCooper Lasersonics, Inc.
Decision Date1986-08-05
Product CodeLLO
Advisory CommitteeEN
DecisionSubstantially Equivalent

Device Summary

6000 ND:YAG LASER FOR BENIGN/MALIGNANT OBSTRUCTION is the device name listed in this FDA 510(k) record. The listed applicant is Cooper Lasersonics, Inc.. It received FDA 510(k) clearance on 1986-08-05 under 510(k) number K862698. The device is classified under product code LLO. It was reviewed by the EN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the 6000 ND:YAG LASER FOR BENIGN/MALIGNANT OBSTRUCTION?

6000 ND:YAG LASER FOR BENIGN/MALIGNANT OBSTRUCTION is a medical device that received FDA 510(k) clearance on 1986-08-05. The listed applicant is Cooper Lasersonics, Inc.. The 510(k) number is K862698.

When did 6000 ND:YAG LASER FOR BENIGN/MALIGNANT OBSTRUCTION receive FDA 510(k) clearance?

6000 ND:YAG LASER FOR BENIGN/MALIGNANT OBSTRUCTION received FDA 510(k) clearance on 1986-08-05, under 510(k) number K862698.

Who is the listed applicant for 6000 ND:YAG LASER FOR BENIGN/MALIGNANT OBSTRUCTION?

The FDA 510(k) record lists Cooper Lasersonics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for 6000 ND:YAG LASER FOR BENIGN/MALIGNANT OBSTRUCTION?

The FDA product code for 6000 ND:YAG LASER FOR BENIGN/MALIGNANT OBSTRUCTION is LLO.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Cooper Lasersonics, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K880427ILLUMINA 40 CO2 LASER SYSTEMK880808ILLUMINA MODEL 40 CO2 LASER FOR GENERAL/PLASTIC SUK880428ILLUMINA 25 CO2 LASER SYSTEMK880429ILLUMINA 55 CO2 LASER SYSTEMK880807ILLUMINA MODEL 25 CO2 LASER FOR GENERAL/PLASTIC SUK880809ILLUMINA MODEL 55 CO2 LASER FOR GENERAL/PLASTIC SU

View all 54 devices →

Related Devices (Code: LLO)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K884815SLT CLMD CONTACT LASERSurgical Laser Technologies, Inc.K881499SURGILASE YAG 100 FOR GYNECOLOGY USESurgilase, Inc.K880592LASEGUIDE 600A, 600B, 400A, 400B FOR PULMONARY USELaser Peripherals, LLCK880170MODEL 4900 ND:YAG LASER FOR PULMONARY OBSTRUCTIONSCooper Lasersonics, Inc.K874254ND:YAG SURGICAL LASER FOR PULMONARY APPLICATIONSMinnesota Laser Corp.K875104SURGI-LIGHT DISPOSABLE SYSTEM FOR PULMONOLOGY USELaserguide

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑